topotecan has been researched along with Pregnancy in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Brinkhuis, RF; Jonker, JW; Maliepaard, M; Schellens, JH; Schinkel, AH; Smit, JW | 1 |
| Abd-Ellah, MF; Ahmad, SF; Attia, SM; Bakheet, SA; Hamada, FM | 1 |
| Beijnen, JH; Buitelaar, M; Elferink, RP; Jonker, JW; Kuipers, F; Plosch, T; Rosing, H; Scheffer, GL; Scheper, RJ; Schinkel, AH; Van Der Valk, MA; Wagenaar, E | 1 |
| Beck, WT; Ee, PL; He, X; Ross, DD | 1 |
| Shen, J; Sun, Z | 1 |
| Leslie, KK | 1 |
1 review(s) available for topotecan and Pregnancy
| Article | Year |
|---|---|
[DNA topoisomerase I inhibitor in the treatment of ovarian neoplasm].
Topics: Antineoplastic Agents; Female; Humans; Ovarian Neoplasms; Pregnancy; Topoisomerase I Inhibitors; Topotecan | 1999 |
5 other study(ies) available for topotecan and Pregnancy
| Article | Year |
|---|---|
Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.
Topics: Acridines; Administration, Oral; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Availability; DNA, Complementary; Enzyme Inhibitors; Female; Fetus; Humans; Intestinal Absorption; Isoquinolines; Male; Mice; Mitoxantrone; Neoplasm Proteins; Placenta; Pregnancy; RNA, Messenger; Tetrahydroisoquinolines; Topotecan | 2000 |
Germ cell mutagenicity of topoisomerase I inhibitor topotecan detected in the male mouse-dominant lethal study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Animals; Antineoplastic Agents; Deoxyguanosine; Dose-Response Relationship, Drug; Female; Free Radical Scavengers; Male; Mice; Mutagenicity Tests; Mutagens; Pregnancy; Reactive Oxygen Species; Spermatozoa; Topoisomerase I Inhibitors; Topotecan | 2013 |
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bone Marrow Transplantation; Cell Line; Chlorophyll; Chromatography, High Pressure Liquid; Dermatitis, Phototoxic; Diet; Drug Resistance; Female; Fetus; Fibroblasts; Genetic Predisposition to Disease; Medicago sativa; Mice; Mice, Inbred Strains; Mice, Knockout; Molecular Structure; Neoplasm Proteins; Photosensitizing Agents; Porphyria, Hepatoerythropoietic; Porphyrins; Pregnancy; Protoporphyrins; Radiation Chimera; Topotecan | 2002 |
Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interference.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cells; Choriocarcinoma; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Estradiol; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Mitoxantrone; Neoplasm Proteins; Pregnancy; RNA Interference; RNA, Messenger; Topotecan; Tumor Cells, Cultured; Uterine Neoplasms | 2004 |
Chemotherapy and pregnancy.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cytarabine; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Fetus; Humans; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Topotecan; Trastuzumab; Vinblastine; Vincristine | 2002 |